Purpose. Under certain circumstances, Actinomyces behaves as an opportunistic microorganism and can cause actinomycosis, a chronic and inflammatory granulomatous infection. The purpose of this project was to detect the presence of Actinomyces in cervical exudates from women with cervical intraepithelial neoplasia (CIN) and women with cervical cancer.
INTRODUCTION
Actinomyces is a bacterial genus that belongs to the order Actinomycetales and the phylum Actinobacteria, species of which are characterized by having 69--78 % guaninecytosine (GC) content in their DNA [1, 2] . Actinomyces species are Gram-positive anaerobic or microaerophilic bacteria, which are non-motile and non-spore-forming and present filamentous growth [3] . Saprophytic Actinomyces species [1] form part of the microbiotas of the oropharynx, gastrointestinal tract and urogenital tract [4] . Under certain circumstances, Actinomyces species become opportunistic and can cause actinomycosis, which is an inflammatory and chronic suppurative granulomatous infection that forms abscesses and fistulas [5] and often mimics malignant tumours, tuberculosis and nocardiosis [4] . These bacteria have a very low virulence potential linked to their fimbriae, which require interruption of the normal mucosal barriers [6] by trauma, a neoplasia, surgery, or an infection [7, 8] . It has been proven that they can infect the cervicofacial, thoracic, abdominal and pelvic areas [4, 9] .
Currently, there is a shortage of epidemiological studies that provide information about the prevalence of pelvic actinomycosis, given the difficulties of the standard culture and identification techniques, which result in the use of molecular techniques instead [8, 10] . There are, however, retrospective studies that have reported 'microorganisms similar to Actinomyces' (MSA) in a number of women, as revealed through Papanicolaou (Pap) tests [3, [11] [12] [13] . As the Pap test lacks specificity and sensitivity for bacterial identification, Actinomyces spp. are not reported at the species level [14] . The identification of Actinomyces species is complicated, and clinical and chemical findings from cases of pelvic actinomycosis are non-specific [8, 15, 16] . Therefore, a technique that allows for the quick and specific detection of Actinomyces species in samples of cervical exudates is required.
Given the opportunistic nature of these bacteria, it would be interesting to study their behaviour in conditions such as cancer and premalignant lesions, which are bodies that involve immunosuppression [17] . For this reason, in this study we analysed the frequency of Actinomyces in women with cervical intraepithelial neoplasia (CIN, a premalignant condition that is divided into three stages, CIN 1, CIN 2 and CIN 3, depending on the thickness of the compromised cervical epithelium) [18] and women with cervical cancer, and compared the results with those for women without cancer or CIN.
METHODS

Study participants
A cross-sectional study was carried out on a total of 70 cases from two hospitals in the central area of Mexico from 2015 through 2016, after approval by the local ethics and research committees at both hospitals. Twenty-two healthy women were included as controls. The characteristics of the participants in the three study groups were as follows. 
Sample collection
The objective of the project was explained to all the participants and they were asked to sign an informed consent form. Thereafter, they were given a questionnaire about their obstetrical and gynaecological history. The samples of cervical exudates taken were transported in screw-top test tubes in thioglycolate solution. In the case of patients with cervical cancer, both in situ and locally advanced, the samples were taken before the women had received any cancer treatment.
Metagenomic DNA extraction
The DNA extraction was carried out following the protocol of the QIAamp UCP Pathogen Mini Kit from Qiagen (Cat. no. 50214). The quality of the extracted DNA was evaluated through 1 % agarose gel electrophoresis.
Detection of the order Actinomycetales
To detect the presence of bacteria of the order Actinomycetales from the metagenomic DNA, a specific fragment (675 bp) was amplified through PCR using a pair of primers designed specifically for Actinomycetales by Kaya et al. [8] , who also designed primer pairs for species of Actinomyces (A. israelii, A. viscosus, A. naeslundii, A. meyeri and A. odontolyticus) from their 16S rRNA sequences. The sequences of the specific primers and the expected length of the PCR products are shown in Table 1 .
Detection of species of Actinomyces
The samples with an enhanced band of expected size (675 bp) for Actinomycetales underwent separate amplifications with the primer pairs for each species of Actinomyces. The PCRs for the Actinomycetales and Actinomyces species were carried out in a total volume of 25 µl containing PCR buffer, 10 pmol of each of the forward and reverse primers, 1 U of DNA Taq polymerase and 10 µl of DNA sample. All of the PCRs included a negative control containing nuclease-free water.
The PCR was carried out in a thermal cycler using the following conditions: initial denaturation for 10 min at 94 C, followed by 35 cycles of 1 min at 94 C, 1 min at 60 C and 90 s at 72 C. After the main cycle programme was complete, post-elongation was carried out for 10 min at 72 C [8] . The amplified products were observed through 2 % agarose gel electrophoresis.
RESULTS
The most important clinical aspects of each group are as follows.
Group 1. In this group of patients, the average age was 37.5 years, 55 % were married, 50 % did not use any familyplanning method during the time of the study and 52.5 % had used an intrauterine device (IUD) at some point in their lifes. The most common stage of the pathology was CIN 1, occurring in 55 % of the patients. The specific fragment of Actinomycetales was amplified in 10 % of the cervical samples, suggesting the presence of this order. The amplified species-specific fragments of Actinomyces had the following distribution: A. meyeri in one sample, A. viscosus in two samples, A. odontolyticus in one sample, and A. israelii in three samples.
Group 2. In this group of patients, the average age was 50.2 years, 40 % were married, 53.3 % did not use any family-planning method during the time of the study and only 23.3 % had used an IUD at some time in their lifes. The most common stage of the pathology was 2B (i.e. a tumour with parametrial invasion without reaching the pelvic wall), occurring in 56.6 % of the patients. The specific fragment for Actinomycetales was amplified in 36.6 % of the samples. At the species-specific level, A. meyeri was found in 11 samples, A. viscosus in six samples, A. odontolyticus in two samples and A. israelii in two samples.
Group 3. In this group of women, the average age was 40.3 years, 40.9 % were married, 45.45 % did not use any family-planning method at the time of the study and only 9 % had used an IUD at some point in their lifes. The presence of Actinomycetales was detected in 9 % of the samples. A. meyeri was found in two samples, A. viscosus in two samples, A. odontolyticus in one sample and A. israelii in one sample. Table 2 shows the general characteristics of the three study groups. Table 3 shows the clinical characteristics of the patients whose samples showed the presence of Actinomyces.
DISCUSSION
This study shows the relative frequency of Actinomyces in the vaginal tract of women with precancerous lesions, women with locally advanced and metastatic cervical cancer, and healthy women. Actinomyces was found in 10 % of the women with CIN, 36.6 % of the women with cervical cancer and 9 % of the healthy women. Although the results coincided with those of some studies carried out with healthy women, our study observed that the prevalence of Actinomyces was highest in women with cervical cancer.
In a study carried out in Mexico, Ramos et al. [19] identified a 7 % prevalence of Actinomyces in cervicovaginal secretions; all the women had used an IUD, and only two of them had symptoms of infection. Kaya et al. [8] identified an 8 % prevalence of Actinomycetales among 200 samples, of which eight (4 %) were found to be positive for species of Actinomyces.
However, there is a discrepancy between the results of different studies with regard to the prevalence of Actinomyces in the vaginal tract. For example, Kim et al. [20] found a 7 % rate of positive MSA in cervical smears from women using IUDs, with the occurrence varying according to the type and duration of use of the device. From 20 390 cervical samples, examined through Pap tests, they found MSA in 52 samples (0.26 %), of which 42 women (80.8 %) were IUD users. Demirezen et al. [3] observed MSA in 19 (0.83 %) of a total of 2290 cervicovaginal samples, also through Pap tests. This variation in results may be due to the different methods used for detecting Actinomyces, as well as the different sample sizes.
The identification of bacteria through molecular biology techniques is an efficient method, but it is more costly than culturing or Pap testing. In the case of Actinomyces species, which are slow-growing bacteria with strict growth conditions, molecular techniques are found to be more efficient and much more sensitive than culturing or Pap testing. Culturing may fail for various reasons, such as previous treatment with antibiotics or poor methodology [10] . Likewise, Kaya et al. [8] showed the advantages of PCR for Pap smears and demonstrated the low sensitivity of anaerobic bacteria culturing, mentioning that analysis through PCR appears to be a sensitive, precise and highly discriminatory diagnostic and classification method for Actinomyces species of clinical origin.
In our study, A. meyeri was found in 14 (15.2 %), A. viscosus in 10 (10.8 %), A. odontolyticus in four (4.3 %) and A. israelii in six (6.5 %) of the 92 samples tested. Of the species reported in this study, A. odontolyticus is generally found in the mouths of babies as well as in early dental bacterial plaque. Other species of Actinomyces, such as A. georgiae, A. gerencseriae, A. israelii, A. naeslundii and A. meyeri, have been found in gingival crevices, both in individuals with full periodontal health and in those without. In general, Actinomyces species have been isolated from supragingival and subgingival plaques, tonsils, dentin, root surfaces, carious processes, periodontal pockets and infected root canals [21] .
A. israelii is one of the most commonly reported species in cases of pelvic actinomycosis, as shown by the study by Schaal et al. [22] , in which 588 (56.4 %) of 1042 examined cases of actinomycosis carried the pathogen. Although in our study A. israelii was found in six of the 17 samples in which the presence of Actinomyces was detected, it was not the most common species. This leads us to question whether A. israelii is the most virulent species for humans, given that its mere presence is not indicative of actinomycosis, despite the fact that it has been found more frequently in Table 2 . General characteristics of the study groups In contrast to the study by Schaal et al. [22] , A. meyeri was the species with the highest prevalence in our study. Whether the differences are due to biogeographical or racial effects or originate from socioeconomic conditions merits further study.
The virulence and pathogenicity of these microorganisms may increase as a result of two important factors: one is the addition of the colonies in a cohesive way, and the other is the adherence of the bacteria to the host cells, which can be achieved through the surface or through proteins secreted by Actinomyces species, such as neuraminidase (sialidase) or superficial bacterial lectins. These factors protect bacteria from being swept away by normal cleaning and physiological functions, such as menstrual flow [3] .
The relationship between the use of IUDs and the presence of Actinomyces is well documented in the literature. In this study, because neoplasia treatments required the patients to stop using IUDs, the time since the patients had stopped using the devices was a very prolonged period. For this reason, no relationship between the use of IUDs and the bacteria was found.
There is currently not enough information about the changes that occur in the microbiota of patients with cervical cancer, and it is not known how this varies with time. However, the cellular changes that are associated with this disease, in addition to environmental changes, could favour the presence of different microorganisms, both aerobic and anaerobic. From the results of this study, it is evident that there are significant changes in patients with cervical cancer, at least in the population of Actinomyces. The meaning of these findings is not yet understood on either the microbiological or the molecular level.
On the other hand, there are indeed reports about changes in the microbiota of human papillomavirus (HPV)-positive and HPV-negative patients. As Gao et al. [23] found, the bacterial diversity and composition are more complex in HPV-positive women than in HPV-negative women. Gardnerella vaginalis and Lactobacillus gasseri have been detected significantly more frequently in those positive for HPV. With regard to intracervical neoplasia, Oh et al. [24] reported that a microbial cervical composition characterized by the predominance of Atopobium vaginae, G. vaginalis and Lactobacillus iners, with a concomitant lack of Lactobacillus crispatus, is associated with a high risk of CIN. Mitra et al. [25] suggested that Lactobacillus jensenii and Lactobacillus coleohominis could be particularly protective in preventing the progression of dysplasia and, ultimately, a carcinogenic process, given that they were detected with higher prevalence in women with low-grade squamous intraepithelial lesions compared to women with high-grade lesions.
However, more information is needed to understand the molecular mechanisms involved in the complex role that the bacterial communities may play in the development of cancer (and vice versa), and what influence cancer could have on the prevalence of the different bacterial communities. Moreover, further studies may allow us to consider the presence or increase of Actinomyces (or one of the species in particular) in the microbiota population as an aid in the early diagnosis of some of these pathological conditions.
In conclusion, in our sample, which included women with CIN or cervical cancer, the presence of Actinomyces was detected in 18.47 % with the use of specific primers for each species of this genus, which facilitated their detection in comparison with traditional isolation methods. This is the first study in which the presence of Actinomyces species has been detected in cervical samples from women, with and without neoplastic changes, using species-specific primers.
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